NRF2 Is a Major Target of ARF in p53-Independent Tumor Suppression

Area of Science:

• Oncology
• Molecular Biology
• Cellular Stress Response

Background:

• The tumor suppressor ARF (Alternative Reading Frame) is known to inhibit tumor growth via p53.
• Mechanisms of ARF-mediated tumor suppression independent of p53 are not fully understood.

Purpose of the Study:

• To elucidate the p53-independent mechanisms of ARF tumor suppression.
• To identify novel regulators and pathways targeted by ARF.

Main Methods:

• Complex purification to identify ARF-interacting proteins.
• Analysis of NRF2 transcriptional activity and target gene expression (e.g., SLC7A11).
• Assessment of ferroptosis sensitivity and cancer cell survival under oxidative stress.
• Evaluation of tumor growth in p53-independent mouse xenograft models with NRF2 modulation.

Main Results:

• ARF was identified as a key regulator of nuclear factor E2-related factor 2 (NRF2).
• ARF inhibits NRF2's transcriptional activation of target genes, including SLC7A11, which is crucial for ferroptosis.
• ARF expression sensitizes cells to ferroptosis in a p53-independent manner.
• ARF depletion promotes cancer cell survival by activating NRF2 during oxidative stress.
• NRF2 overexpression abrogated ARF's p53-independent tumor growth suppression in vivo.

Conclusions:

• NRF2 is a major target of ARF's p53-independent tumor suppressive function.
• The ARF-NRF2 interaction represents a novel checkpoint in cellular oxidative stress responses.
• Targeting the ARF-NRF2 pathway may offer new therapeutic strategies for cancer treatment.